Dixon Investments Inc. dba ARI – 710087 – 09/17/2025

Section 505B(d)(1) requires FDA to send a PREA Non-Compliance letter to sponsors who have failed to submit their pediatric assessments required under PREA by the final due date, have failed to seek or obtain a deferral or deferral extension.

Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 06/28/2023
Short Title (70 char) ByHeart Inc. dba BlendHouse Allerton. Allerton, IA. EIR issued 06/28/2023
FEI Number 1921383
Firm Name ByHeart Inc. dba BlendHouse Allerton
Record Type EIR
State IA
Establishment

CGMP/Finished Pharmaceuticals/Adulterated

Educational Resources

The Food and Drug Administration is advising consumers not to purchase or use LOVION Chocolate with Ginseng for Men, a product promoted and sold for sexual enhancement on various websites, including lovionusa.com, and possibly in some retail stores.

Compounding Pharmacy/Adulterated Drug Products